# Reduction of Intravenous Antibiotics In Neonates

> **NCT03247920** · PHASE4 · COMPLETED · sponsor: **Franciscus Gasthuis** · enrollment: 510 (actual)

## Conditions studied

- Neonatal Infection
- Neonatal SEPSIS

## Interventions

- **DRUG:** Amoxicillin Clavulanate
- **DRUG:** Antibiotics

## Key facts

- **NCT ID:** NCT03247920
- **Lead sponsor:** Franciscus Gasthuis
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-04
- **Primary completion:** 2021-06-15
- **Final completion:** 2021-07-15
- **Target enrollment:** 510 (ACTUAL)
- **Last updated:** 2021-08-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03247920

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03247920, "Reduction of Intravenous Antibiotics In Neonates". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03247920. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*